News

Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, today announced the introduction of Prostate Px+, the first commercial test to predict prostate cancer progression and disease recurrence at the time of diagnosis.
| 2 min read

Palo Alto, Calif., 13 May, 2008 / On 2 April, 2008, Varian, Inc. (Nasdaq: VARI) acquired the assets and products of Precision Detectors, Inc., a privately owned company based in Bellingham, Massachusetts.
| 2 min read

Thermo Fisher Scientific is pleased to introduce LIFECYCLE Enterprise Solutions, a quarterly e-newsletter that will provide the laboratory industry with educational white papers, case studies and best practices on how to reduce total cost of ownership, increase instrument and equipment performance, improve productivity and ensure compliance.
| 1 min read







